WinstonWınston
Stock

RH Bophelo Limited

RHB.JO
43
Asset Management · Financial Services
Price
180.00 ZAc
+0.00 (+0.00%)
Market Cap
116.4M ZAc
Exchange
Johannesburg Stock Exchange
Winston Score
43
Winston is serious
Mixed quality — meaningful strengths and weaknesses.
Data as of Sep 20, 2026 · filings through Feb 28, 2026

§How the score breaks down

Quality
Mixed
Growth
Mixed
Cash Flow
Weak
Stability
Strong
Valuation
Good

§Winston Score History

The full picture

RH Bophelo Limited primarily allocates its capital within the healthcare industry in South Africa. The company's investment strategy focuses on equity, quasi-equity, and other equity-linked instruments, targeting operational infrastructure across various sub-sectors. These include health insurance, private hospital facilities, pharmaceuticals, and the retail and distribution networks. The firm was established in 2016, with its headquarters located in Johannesburg, South Africa, and operates as a subsidiary of Public Investment Corporation SOC Limited.

Growth Profile

When traditional metrics don't capture the full picture, these are the signals growth stock investors use instead.

Revenue Growth

+233.6% YoY

YoY Growth Rate

Revenue accelerating

EPS Growth

-101.9% YoY

YoY Growth Rate

Earnings declining

R&D Spend

R0/ year

0.0% of revenue

Below sector average (7%)

Research and development spending

Cash Runway

5+ years

Quarterly Free Cash Flow

↓ Burn rate worsening

R1.2B cash & investments at current burn rate

Revenue accelerating

RH Bophelo Limited grew revenue 234% year-over-year and the growth rate is speeding up. That's the kind of momentum growth investors look for — the question is whether margins can follow.

The Winston Score above measures business quality today. Growth stocks often score lower because they invest in the future rather than maximising current profits. These metrics show what matters most for evaluating that future.

Share count broadly stable

+0.0% over 4y

The share count has stayed roughly flat over this period — little dilution or buyback activity.

Diluted shares outstanding: 64.7M (2022) → 64.7M (2026)

Score breakdown

Every number that matters to educated investors.

Each metric is explained in plain language so you know exactly what you're looking at. Start your free trial now.

Quality

Profit per sale
Gross Margin
95.2%
Premium pricing power — 95.2% gross margin
Profit after running costs
Operating Margin
-4.1%
Losing money on operations — -4.1%
Return on the money invested
ROCE
2.4%
Weak — 2.4% return on capital

ROIC between 0% and 5%. They earn a few cents back per dollar invested in the business.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Growth

Sales growth
Sales YoY
+124.9%
Fast-growing sales (+124.9% YoY)
Profit growth
EPS YoY
-58.4%
Earnings shrinking (-58.4% YoY)

Earnings per share down more than 10%. Either a bad year, or a real decline.

How steady the profit is
EPS Consistency
3/8 quarters
Earnings rarely grow — volatile business

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Cash Flow

Profit that turns into cash
Cash Conversion
-89%
Weak — only -89% of profit becomes cash
Spare cash per sale
FCF Margin
-18.4%
Burning cash (-18.4%)

Free cash flow is negative. They are burning cash, not generating it.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Stability

What it owes vs what it owns
Debt / Equity
0.03
Conservative — low debt load (0.03)
Covers its interest
Interest Cover
2.29x
Tight — interest eats into profit (2.3x)

Interest coverage between 1 and 3. Profits cover interest, but with little room to spare.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Valuation

Price vs profit
P/E Ratio (TTM)
6.4x
Attractive valuation — P/E 6.4

P/E under 10. The price tag is small relative to last year's profit.

Cheaper or dearer next year
P/E vs Forward
N/A
not available
Data not available

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Dividends

Not applicable for this business.
🔒 See full fundamentals and if they are improving or declining — click here for your free trial now.
Start free trial